Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives

Prostate cancer (PC) is the most common type of tumor in men. In the early stage of the disease, it is sensitive to androgen deprivation therapy. In patients with metastatic castration-sensitive prostate cancer (mHSPC), chemotherapy and second-generation androgen receptor therapy have led to increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Maselli, Felicia Maria, Giuliani, Francesco, Laface, Carmelo, Perrone, Martina, Melaccio, Assunta, De Santis, Pierluigi, Santoro, Anna Natalizia, Guarini, Chiara, Iaia, Maria Laura, Fedele, Palma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297468/
https://www.ncbi.nlm.nih.gov/pubmed/37366915
http://dx.doi.org/10.3390/curroncol30060432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297468/
https://www.ncbi.nlm.nih.gov/pubmed/37366915
http://dx.doi.org/10.3390/curroncol30060432

Ejemplares similares